Psyence Biomedical (PBMWW) Stock: Why It Moved Today
Updated Oct 20, 2026, 12:04 PM ET · intraday price
- Trading at $0.02 as of 12:04 PM ET, +0.00% vs the prior close of $0.02.
- New SEC filings: SCHEDULE 13D/A (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
PBMWW is flat (+0.0%) to $0.02. Trading at $0.02 (intraday, 12:04 PM ET), +0.00% vs the prior close of $0.02. Day range $0.02–$0.02, opened at $0.02.
PBMWW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — PBMWW is flat (+0.0%) to $0.02
- Trading at $0.02 (intraday, 12:04 PM ET), +0.00% vs the prior close of $0.02. Day range $0.02–$0.02, opened at $0.02.
- 52-week range $0.02–$0.02; the current price sits at 1% of that range, 30.0% below the 52-week high.
PBMWW bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
PBMWW latest news & SEC filings
Every SEC filing by or about PBMWW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 5, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 5, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 26, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 26, 2026 · Form F-3 — F-3 filing
F-3 filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 22, 2026 · Form 20-F — Annual report from a foreign company (20-F)
Annual report from a foreign company (20-F)
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Things to know before you trade PBMWW
- How much it moves: over the last 20 sessions the average daily move was 0.00% (largest 0.0%). That is a relatively calm stock.
- Liquidity: about 220 shares (≈$4) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.02 vs a range of $0.02–$0.02 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 5, 2026; 6-K Sep 28, 2026; 6-K Sep 23, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PBMWW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 439 |
| Oct 14, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 0 |
About Psyence Biomedical
Psyence Biomedical (PBMWW) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in TORONTO. State of incorporation: Ontario, Canada. Fiscal year ends March 31. SEC CIK 1985062.
PBMWW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
PBMWW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
PBMWW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)United Therapeutics (UTHR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on PBMWW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 12:04 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.